Eli Lilly and Company operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other
companies in this sector in UNITED STATES :
Abbott Laboratories
(2020
sales of $34.61 billion
of which 34%
was Medical Devices),
Regeneron Pharmaceuticals Incorporated
($8.50 billion
of which 58%
was EYLEA), and
Viatris Inc
($11.95 billion
of which 71%
was Developed markets).
Sales Analysis.
Eli Lilly and Company reported sales of $24.54 billion
for the
year ending
December of 2020.
This
represents
an
increase of 9.9%
versus 2019, when the company's sales were $22.32 billion.
Despite this increase, sales are still
slightly
below the level achieved in 2018, when Eli Lilly and Company
reported sales of $24.56 billion.